ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

12,626Medicare Part D Prescriptions Filled, Including Refills

Rank: 12 out of 623

$567K Total Retail Price of All Prescriptions

Rank: 28 out of 623

258 Patients Receiving at Least One Drug in Part D
88%Patients 65 Years and Older
95% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Maryland
Lower avg

Schedule Two
Controlled Substances

14% of this provider’s 258 patients filled at least one prescription for a schedule two drug, compared to an average of 6%.

Schedule Three
Controlled Substances

N/A

Risky Drugs to Seniors

0% of this provider’s 10,197 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

20% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$45 was the average price of a prescription from this provider, compared to $66 among peers.

Prescriptions per Patient

49 is the average number of prescriptions (including refills) per patient, compared to an average of 16.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Maryland
FUROSEMIDE 522 460 1 5
WARFARIN SODIUM 470 338 2 14
SERTRALINE HCL 423 335 3 20
TRAMADOL HCL 422 353 4 15
LEVOTHYROXINE SODIUM 375 335 5 4
CITALOPRAM HBR 359 288 6 21
GABAPENTIN 348 220 7 18
LISINOPRIL 345 291 8 1
AMLODIPINE BESYLATE 299 263 9 3
METOPROLOL TARTRATE 284 259 10 9
DIVALPROEX SODIUM 276 251 11 77
RISPERIDONE 227 194 12 49
IPRATROPIUM-ALBUTEROL 226 187 13 91
GENERLAC 222 137 14 158
METOPROLOL SUCCINATE 222 178 14 13
LANTUS 217 154 16 41
LEVETIRACETAM 211 128 17 83
SIMVASTATIN 197 120 18 2
TRAZODONE HCL 192 134 19 36
TAMSULOSIN HCL 185 171 20 35
MIRTAZAPINE 167 165 21 31
PREDNISONE 139 120 22 40
NYSTOP 138 90 23 175
DONEPEZIL HCL 130 122 24 27
METFORMIN HCL 128 87 25 6
BACLOFEN 119 31 26 115
KLOR-CON M20 114 92 27 62
PAROXETINE HCL 110 85 28 66
CYMBALTA 105 87 29 52
CLONIDINE HCL 104 84 30 55
POLYETHYLENE GLYCOL 3350 104 83 30 53
ADVAIR DISKUS 102 92 32 39
GLIPIZIDE 101 79 33 33
RANITIDINE HCL 94 84 34 23
LEVOFLOXACIN 93 82 35 72
QUETIAPINE FUMARATE 91 91 36 51
ATENOLOL 89 89 37 12
HYDRALAZINE HCL 86 68 38 70
NAMENDA 85 85 39 47
DIGOXIN 77 76 40 63
SULFAMETHOXAZOLE-TRIMETHOPRIM 76 68 41 78
MEDROXYPROGESTERONE ACETATE 73 57 42 236
LOSARTAN POTASSIUM 71 71 43 16
LAMOTRIGINE 71 46 43 201
ATORVASTATIN CALCIUM 66 63 45 10
ENULOSE 63 43 46 252
CLOPIDOGREL 63 45 46 34
NYSTATIN-TRIAMCINOLONE 62 16 48 209
ALLOPURINOL 60 60 49 44
PRAVASTATIN SODIUM 59 46 50 11
HYDROCHLOROTHIAZIDE 59 49 50 8
LEVEMIR 58 57 52 196
OMEPRAZOLE 57 44 53 7
CIPROFLOXACIN HCL 56 46 54 61
ESCITALOPRAM OXALATE 55 45 55 60
TRAVATAN Z 55 55 55 215
DILTIAZEM 24HR CD 53 53 57 180
CARBIDOPA-LEVODOPA 52 52 58 88
METOCLOPRAMIDE HCL 52 12 58 165
SEROQUEL 52 52 58 129
PLAVIX 51 46 61 46
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.